Quick Answer
Cardiff Oncology, Inc. reported Total Revenue of $593.0 thousand for fiscal year 2025.
Cardiff Oncology, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $593.0K | -13.2% |
| 2024 | $683.0K | +40.0% |
| 2023 | $488.0K | +26.4% |
| 2022 | $386.0K | +7.5% |
| 2021 | $359.0K | -1.9% |
| 2020 | $366.0K | +49.6% |
| 2019 | $244.6K | -35.3% |
| 2018 | $378.3K | -25.1% |
| 2017 | $505.4K | +32.6% |
| 2016 | $381.1K | +21.8% |
| 2015 | $312.8K | +11.6% |
| 2014 | $280.2K | +8.1% |
| 2013 | $259.2K | -42.4% |
| 2012 | $450.4K | +74.8% |
| 2011 | $257.7K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $120.0K | -27.3% | -0.8% |
| June 30, 2025 | $121.0K | -25.8% | +11.0% |
| March 31, 2025 | $109.0K | -46.8% | -33.9% |
| September 30, 2024 | $165.0K | +17.0% | +1.2% |
| June 30, 2024 | $163.0K | +50.9% | -20.5% |
| March 31, 2024 | $205.0K | +147.0% | +45.4% |
| September 30, 2023 | $141.0K | +51.6% | +30.6% |
| June 30, 2023 | $108.0K | +18.7% | +30.1% |
- Cardiff Oncology, Inc. showed a decrease of -13.2% in Total Revenue compared to the prior fiscal year.
- Over the 2011–2025 period, Cardiff Oncology, Inc.’s total revenue has grown by 130.1% (from $257.7 thousand to $593.0 thousand).
- The most recent figure is from Cardiff Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: